1001 related articles for article (PubMed ID: 1655948)
1. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.
de Waal Malefyt R; Haanen J; Spits H; Roncarolo MG; te Velde A; Figdor C; Johnson K; Kastelein R; Yssel H; de Vries JE
J Exp Med; 1991 Oct; 174(4):915-24. PubMed ID: 1655948
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
[TBL] [Abstract][Full Text] [Related]
3. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
[TBL] [Abstract][Full Text] [Related]
4. Antigen presentation by human monocytes: effects of modifying major histocompatibility complex class II antigen expression and interleukin 1 production by using recombinant interferons and corticosteroids.
Rhodes J; Ivanyi J; Cozens P
Eur J Immunol; 1986 Apr; 16(4):370-5. PubMed ID: 2422040
[TBL] [Abstract][Full Text] [Related]
5. Activation with superantigens induces programmed death in antigen-primed CD4+ class II+ major histocompatibility complex T lymphocytes via a CD11a/CD18-dependent mechanism.
Damle NK; Leytze G; Klussman K; Ledbetter JA
Eur J Immunol; 1993 Jul; 23(7):1513-22. PubMed ID: 8100773
[TBL] [Abstract][Full Text] [Related]
6. Discrimination of human CD4 T cell clones based on their reactivity with antigen-presenting T cells.
Wyss-Coray T; Brander C; Frutig K; Pichler WJ
Eur J Immunol; 1992 Sep; 22(9):2295-302. PubMed ID: 1381313
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
[TBL] [Abstract][Full Text] [Related]
8. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
Yamamoto M; Yano A
J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells.
Brossart P; Zobywalski A; Grünebach F; Behnke L; Stuhler G; Reichardt VL; Kanz L; Brugger W
Cancer Res; 2000 Aug; 60(16):4485-92. PubMed ID: 10969796
[TBL] [Abstract][Full Text] [Related]
10. Human major group rhinoviruses downmodulate the accessory function of monocytes by inducing IL-10.
Stöckl J; Vetr H; Majdic O; Zlabinger G; Kuechler E; Knapp W
J Clin Invest; 1999 Oct; 104(7):957-65. PubMed ID: 10510336
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression.
Matsuda M; Salazar F; Petersson M; Masucci G; Hansson J; Pisa P; Zhang QJ; Masucci MG; Kiessling R
J Exp Med; 1994 Dec; 180(6):2371-6. PubMed ID: 7964510
[TBL] [Abstract][Full Text] [Related]
12. Class II major histocompatibility complex restriction of human T cell responses to short ragweed allergen, Amb a V.
Huang SK; Zwollo P; Marsh DG
Eur J Immunol; 1991 Jun; 21(6):1469-73. PubMed ID: 2044656
[TBL] [Abstract][Full Text] [Related]
13. Antigen-presenting human T cells and antigen-presenting B cells induce a similar cytokine profile in specific T cell clones.
Wyss-Coray T; Gallati H; Pracht I; Limat A; Mauri D; Frutig K; Pichler WJ
Eur J Immunol; 1993 Dec; 23(12):3350-7. PubMed ID: 7504995
[TBL] [Abstract][Full Text] [Related]
14. Ligation of TAPA-1 (CD81) or major histocompatibility complex class II in co-cultures of human B and T lymphocytes enhances interleukin-4 synthesis by antigen-specific CD4+ T cells.
Secrist H; Levy S; DeKruyff RH; Umetsu DT
Eur J Immunol; 1996 Jul; 26(7):1435-42. PubMed ID: 8766544
[TBL] [Abstract][Full Text] [Related]
15. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
Geppert TD; Lipsky PE
J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
[TBL] [Abstract][Full Text] [Related]
16. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of interleukin-10 on the expression of HLA class II and CD1 molecules induced by granulocyte/macrophage colony-stimulating factor/interleukin-4.
Thomssen H; Kahan M; Londei M
Eur J Immunol; 1995 Sep; 25(9):2465-70. PubMed ID: 7589112
[TBL] [Abstract][Full Text] [Related]
18. MHC class II-restricted presentation of endogenously synthesized antigen: Epstein-Barr virus transformed B cell lines can present the viral glycoprotein gp340 by two distinct pathways.
Lee SP; Wallace LE; Mackett M; Arrand JR; Searle PF; Rowe M; Rickinson AB
Int Immunol; 1993 May; 5(5):451-60. PubMed ID: 8391306
[TBL] [Abstract][Full Text] [Related]
19. The proliferative immune response to autologous Epstein-Barr virus transformed lymphoblastoid cells. II. Studies with HLA class II loss variants demonstrate a role for gene products other than DR and DQ.
Reitnauer PJ; DeMars R; Sondel PM
Hum Immunol; 1986 Jul; 16(3):276-88. PubMed ID: 3013814
[TBL] [Abstract][Full Text] [Related]
20. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
de Waal Malefyt R; Yssel H; de Vries JE
J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]